Lumentum (LITE) shares were volatile around recent analyst target changes and a fresh quarterly report. The stock traded at $626.87, down 1.52% on the session, after a 24-hour range of $615.13 to $...
Lumentum (LITE) has been trading against two clear inputs: a strong fiscal first-quarter update and a fresh wave of analyst target changes. On November 2, Lumentum reported first-quarter fiscal 2027 net revenue of $1.26 billion, GAAP gross margin of 51.0%, non-GAAP gross margin of 53.2%, and said it expects second-quarter revenue of $1.575 billion to $1.625 billion, with non-GAAP diluted net income per share of $5.90 to $6.20. Management also said pump lasers and optical circuit switches were the leading contributors, and noted a second major NPO/CPO win backed by purchase commitments exceeding $5 billion.
That backdrop has not produced a clean one-way read on the stock. Benzinga reported on November 11 that LITE rose more than 14% as broader tech strength coincided with analyst recalibration. UBS kept a Neutral rating but cut its target to $686 from $960, while Bernstein reiterated Outperform and lifted its target to $700 from $635. B. Riley had already downgraded the stock to Neutral on November 3 and cut its target to $770.
The analyst tape is still constructive at the aggregate level, but the spread matters. StockAnalysis says 25 analysts polled by S&P Global show a consensus Buy, with an average target of $1,069, a low of $685, and a high of $1,425. 60, a low of $685, and a high of $1,400.
Source link







